Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors

doi:10.3748/wjg.v24.i44.5046

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 44

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7362)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-8) series.

Item

Count

PDF

511

WORD

236

HTML

4349

Figures (1-3)

186

Tables (1-8)

157

Sum=5439

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

816

Download

1107

Sum=1923

Nov 28, 2018 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 28, 2018; 24(44): 5046-5056
Published online Nov 28, 2018. doi: 10.3748/wjg.v24.i44.5046

Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curves for predicting recurrence free survival among 170 gastrointestinal stromal tumor patients. A and B: Plasma fibrinogen (FIB), D-dimer, D-dimer to FIB ratio (D-dimer/FIB), and platelet count. ROC: Receiver operating characteristic ; RFS: Recurrence-free survival; GIST: Gastrointestinal stromal tumor.

Citation: Cai HX, Li XQ, Wang SF. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors. World J Gastroenterol 2018; 24(44): 5046-5056
URL: https://www.wjgnet.com/1007-9327/full/v24/i44/5046.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i44.5046